Shari Marchbein is a Dermatology physician affiliated with NYU Langone Health. OpenAlex indexes 8 publications with 263 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- REVANCE THERAPEUTICS, INC.Program year20252 payments$27,150openpaymentsdata.cms.gov ↗
- REVANCE THERAPEUTICS, INC.Program year20241 payment
- ABBVIE INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
49%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor27.5%Valacyclovir100%Part D<11 patientsAzole Antifungal21.6%Ketoconazole100%Part D<11 patientsSensory organs
27.5%Corticosteroid27.5%Clobetasol Propionate100%Part D<11 patientsMetabolism & gastrointestinal
23.5%Vitamins, other combinations23.5%Azelaic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Macrocystis pyrifera ferment‐containing creams for optimizing facial skin rejuvenation
Journal of Cosmetic Dermatology
2023 - Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens
Journal of Drugs in Dermatology
2021 - Iconography : Androgens in women : Androgen-mediated skin disease and patient evaluation2019
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Faith Davies, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Robert Modlin, MD
University of California, Los Angeles
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Joel Gelfand, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”